Answers are grounded in this paper and cite their sources.
Investigation shows acute IL-6 and cathepsin B changes in resistance training, suggesting benefits even far from failure.
This investigation employed a between-participant design comparing acute and chronic changes in brain-derived neurotrophic factor (BDNF), cathepsin B (CatB), insulin-like growth factor-1 (IGF-1), and interleukin-6 (IL-6) across four resistance training (RT) protocols differing in proximity to failure, while also examining inter-biomarker correlations. Thirty-eight resistance-trained men completed an eight-week intervention, training three times per week, allocated to one of four groups based on repetitions-in-reserve (RIR): 4–6 RIR, 1–3 RIR, 0–3 RIR, and 0 RIR. Serum was collected immediately before and after training on day 1 of weeks 1 and 7. The analysis revealed the main effects of Session for BDNF and IL-6 (posterior probability > 99%), indicating exercise-induced elevation independent of proximity to failure. Additionally, CatB demonstrated a Session × Week interaction (posterior probability > 99%), indicating a difference in the acute response between week 7 and week 1. No compelling evidence emerged for IGF-1 effects, and inter-biomarker correlations were weak and inconsistent. Notably, this is the first investigation to demonstrate RT-induced transient CatB elevation. These findings suggest that exercise-induced neuroprotective biomarker responses may be achieved while training relatively far from failure, potentially avoiding the neuromuscular fatigue, injury risk, and recovery demands associated with failure training.
No takes yet. Share an insight, caveat, or question.
Benitez et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: